Exam 3: Basic of Pharmacokinetics I Flashcards
Histamine H2 receptor
-Type of receptor: This is a GPCR really only present significantly in the GI tract
• Stomach
• Small intestine
Its endogenous ligand is histamine
Histamine stimulates gastric acid production
Famotidine H2 receptor
It is a competitive antagonist for histamine
• It blocks histamine from binding, hence less acid is
produced
• It is used to treat GERD
H2 receptors are
transmembrane proteins
•A single peptide with seven membrane spanning regions.
•Ligand binding initiates release of GDP from G-protein subunits from the intracellular side and allows binding instead to GTP
•The result is an increase in activity of adenylyl cyclase.
•Response time: Slow with a duration of seconds to min
GABAa receptor
This is a ligand-gated ion channel expressed in the brain•Its endogenous ligand is gamma-aminobutyric acid (GABA)
•GABA is an inhibitory neurotransmitter
•When GABA binds, it allows chloride ions to pass
•This inhibits neurotransmission
•Response time: Rapid with a duration of milliseconds
Zolpidem is what
is a GABAa receptor agonist
- It binds allosterically to GABAA and helps GABA bind
•This inhibits neurotransmission above and beyond natural levels
•It is used to treat insomnia
GABAs is a protein with
five subunits (a,B, y’s) that are combined to yield a functional receptor
- It has two binding sites for its endogenous ligand GABA that effect Cl- passage through a central pore
- It has one allosteric binding site for benzodiazepines
Pharmacokinetics
What body does to drug
The relationship between dose and effect ( dose-concentration)
-ADME
Pharmacodynamics
What drug does to the body Concentration-effect -Receptor-Drug interactions - Cell signaling/2nd messenger -Receptor expression/gene regulation - Potency and Efficacy
Affinity
- usually expressed as the dissociation constant (Kd)
• KD=concentration of free drug at which half of the receptors are bound
• Concentration of free drug (D)
• Concentration of free receptors (R)
• Concentration of bound drug-receptors (DR)
• Expressed in molar units (µM, nM, pM)
A small/low Kd indicates
high affinity
Formula for finding Kd
Kd = [D][R] / [DR]
As we increase the drug concentration,
we increase the amount of receptor binding
More drug-bound receptor equates
to greater biological effect
Increase in dose results in
increase in plasma conc. which increases the response/effect
EC50
The drug conc. at which yields 50% maximal response
If the receptor has lower affinity for a drug
it will require more of that drug to bind to the same number of receptors
Potency
amount of drug (conc.) needed to produce a certain effect
Efficacy
maximal effect a drug produces regardless of dose
ED50
dose that is therapeutically effective in 50% of the population
TD50
Dose that causes toxic effects in 50% of the population
LD50
Dose that is lethal in 50% of the population (animal)
Therapeutic Index
Ratio between toxic dose and effective dose
• Therapeutic Index (TI) = TD50/ED50
Is it preferable to have:
A. a high therapeutic index or
B. a low therapeutic index?
A. a high therapeutic index
Absorption
Dissolution/liberation of drug from formulation
• Gastric emptying
• Passive/facilitated/active transport through intestinal wall
Metabolism
- Intestinal microbiota
- Enterocyte enzymes
- First pass effect
Distribution
- Highly perfused tissues - Blood, liver, kidney, heart, lungs
- Poorly perfused tissues - Fat, muscle, CSF
Excretion
Filtration/secretion into urine
• Biliary excretion
Cmax
Max observed plasma drug conc.